Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

NCT05270616 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2020-06-01
Last updated
2022-03-08

Condition(s) studied

Lung DiseasesSurgery

Investigational drug(s) / intervention(s)

robotic surgeryuniport surgerymultiple- port surgery

robotic surgery: minimally invasive surgery using the Davinci robotic system

uniport surgery: VATS minimally invasive surgery under the uniportal status

multiple- port surgery: VATS minimally invasive surgery under the multiple- port status

Study summary

To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection.

Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. good cardio- pulmonary function to tolerate surgery; 2. minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy; Exclusion Criteria: 1. cardio- pulmonary function is not good enough to tolerate surgery; 2. huge tumor or extensive adhesion in thoracic cavity.

Primary outcome measure(s)

  • mortality — 30 days after surgery
    incidence rate
  • conversion rate to open surgery — during surgery
    incidence rate
  • postoperative complications — within 7 days after surgery
    incidence rate
  • operation time — within 180 minutes
    minutes
  • duration of hospitalization — within 7 days after surgery
    days
  • days to tube removal — within 7 days after surgery
    days
  • retrieved lymph node — within 1 days after surgery
    amount
  • retrieved lymph node station — within 1 days after surgery
    amount
  • short- term PFS — 3 years
    proportion
  • short- term overall survival — 3 years
    proportion

Trial sites (1)

FacilityCityRegionStatus
The Second Hospital of Shandong University Jinan Shandong Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05270616 on ClinicalTrials.gov ↗ ← All trials in China